BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20521648)

  • 1. Generation and evaluation of a Newcastle disease virus-based H9 avian influenza live vaccine.
    Ge J; Tian G; Zeng X; Jiang Y; Chen H; Bua Z
    Avian Dis; 2010 Mar; 54(1 Suppl):294-6. PubMed ID: 20521648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel recombinant attenuated Newcastle disease virus expressing H9 subtype hemagglutinin protected chickens from challenge by genotype VII virulent Newcastle disease virus and H9N2 avian influenza virus.
    Xu X; Xue C; Liu X; Li J; Fei Y; Liu Z; Mu J; Bi Y; Qian J; Yin R; Ding Z
    Vet Microbiol; 2019 Jan; 228():173-180. PubMed ID: 30593364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza.
    Veits J; Wiesner D; Fuchs W; Hoffmann B; Granzow H; Starick E; Mundt E; Schirrmeier H; Mebatsion T; Mettenleiter TC; Römer-Oberdörfer A
    Proc Natl Acad Sci U S A; 2006 May; 103(21):8197-202. PubMed ID: 16717197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.
    Ge J; Deng G; Wen Z; Tian G; Wang Y; Shi J; Wang X; Li Y; Hu S; Jiang Y; Yang C; Yu K; Bu Z; Chen H
    J Virol; 2007 Jan; 81(1):150-8. PubMed ID: 17050610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Newcastle disease virus recombinant expressing avian influenza virus H6 hemagglutinin against Newcastle disease and low pathogenic avian influenza in chickens and turkeys.
    Schröer D; Veits J; Keil G; Römer-Oberdörfer A; Weber S; Mettenleiter TC
    Avian Dis; 2011 Jun; 55(2):201-11. PubMed ID: 21793434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Newcastle disease virus expressing H9 HA protects chickens against heterologous avian influenza H9N2 virus challenge.
    Nagy A; Lee J; Mena I; Henningson J; Li Y; Ma J; Duff M; Li Y; Lang Y; Yang J; Abdallah F; Richt J; Ali A; García-Sastre A; Ma W
    Vaccine; 2016 May; 34(23):2537-45. PubMed ID: 27102817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease.
    Swayne DE; Suarez DL; Schultz-Cherry S; Tumpey TM; King DJ; Nakaya T; Palese P; Garcia-Sastre A
    Avian Dis; 2003; 47(3 Suppl):1047-50. PubMed ID: 14575108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of recombinant Newcastle disease virus expressing HA protein of H9N2 Avian influenza virus in respiratory and intestinal tract.
    Shao G; Xie Z; Liang M; Liu Y; Song C; Feng K; Zhang X; Lin W; Fu J; Xie Q
    Poult Sci; 2022 Dec; 101(12):102078. PubMed ID: 36272233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels.
    Sarfati-Mizrahi D; Lozano-Dubernard B; Soto-Priante E; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
    Avian Dis; 2010 Mar; 54(1 Suppl):239-41. PubMed ID: 20521638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.
    Zhao J; Yang H; Xu H; Ma Z; Zhang G
    Virol J; 2017 Mar; 14(1):56. PubMed ID: 28302119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Bivalent Inactivated Vaccine Containing Insect Cell-Expressed Avian Influenza H5 and Egg-Based Newcastle Disease Virus (NDV) Against Dual Infection with Highly Pathogenic H5N1 and Velogenic NDV in Chickens.
    Said M; Soliman MA; Mousa S; Arafa A; Hussein HA; Amarin N; Mundt E
    Avian Dis; 2019 Sep; 63(3):474-480. PubMed ID: 31967431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-thermal plasma for inactivated-vaccine preparation.
    Wang G; Zhu R; Yang L; Wang K; Zhang Q; Su X; Yang B; Zhang J; Fang J
    Vaccine; 2016 Feb; 34(8):1126-32. PubMed ID: 26529075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with Newcastle disease virus vectored vaccine protects chickens against highly pathogenic H7 avian influenza virus.
    Schröer D; Veits J; Grund C; Dauber M; Keil G; Granzow H; Mettenleiter TC; Römer-Oberdörfer A
    Avian Dis; 2009 Jun; 53(2):190-7. PubMed ID: 19630223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric Newcastle disease virus-vectored vaccine protects chickens against H9N2 avian influenza virus in the presence of pre-existing NDV immunity.
    Liu J; Xue L; Hu S; Cheng H; Deng Y; Hu Z; Wang X; Liu X
    Arch Virol; 2018 Dec; 163(12):3365-3371. PubMed ID: 30187143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection and differentiation of infected from vaccinated animals by an inactivated recombinant Newcastle disease virus/avian influenza H5 vaccine.
    Lozano-Dubernard B; Soto-Priante E; Sarfati-Mizrahi D; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
    Avian Dis; 2010 Mar; 54(1 Suppl):242-5. PubMed ID: 20521639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric Newcastle Disease Virus-like Particles Containing DC-Binding Peptide-Fused Haemagglutinin Protect Chickens from Virulent Newcastle Disease Virus and H9N2 Avian Influenza Virus Challenge.
    Xu X; Qian J; Qin L; Li J; Xue C; Ding J; Wang W; Ding W; Yin R; Jin N; Ding Z
    Virol Sin; 2020 Aug; 35(4):455-467. PubMed ID: 32274680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and Comparison of the Potential Immunogenicity of Two Commercial Inactivated Bivalent Newcastle and Avian Influenza Vaccines in SPF Chicken.
    Mehrabanpour M
    Arch Razi Inst; 2019 Sep; 74(3):251-257. PubMed ID: 31592590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of avian influenza virus H5 and N1 by recombinant Newcastle disease virus and the impact on immune response in chickens.
    Ramp K; Veits J; Deckers D; Rudolf M; Grund C; Mettenleiter TC; Römer-Oberdörfer A
    Avian Dis; 2011 Sep; 55(3):413-21. PubMed ID: 22017039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and Evaluation of Recombinant Thermostable Newcastle Disease Virus Expressing the HA of H9N2 Avian Influenza Virus.
    Zhang X; Bo Z; Meng C; Chen Y; Zhang C; Cao Y; Wu Y
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus.
    Pan Z; Zhang X; Geng S; Cheng N; Sun L; Liu B; Huang J; Jiao X
    Vaccine; 2009 Feb; 27(7):1018-23. PubMed ID: 19103246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.